Commitments and Contingencies (Details Narrative) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
May 27, 2025 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Prepaid research and development expenses | $ 209,427 | |||
| Accounts payable | 1,929,223 | 1,888,729 | ||
| Yeda Research and License Agreement [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Research and development expense | 14,500 | $ 14,500 | ||
| Accrued research and development expenses | 145,000 | 130,500 | ||
| MD Anderson Agreements [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Research and development expense | 445,000 | $ 324,000 | ||
| Additional payment | $ 327,000 | |||
| Prepaid research and development expenses | 209,427 | |||
| Accrued research and development | 343,544 | 16,545 | ||
| Accounts payable | $ 1,114,372 | $ 1,189,372 | ||
| X | ||||||||||
- Definition Accrued research and development. No definition available.
|
| X | ||||||||||
- Definition Prepaid expenses - research and development. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|